brca3 | 59563
Genetics Carriership of a familial variant
Keywords
ATM, BARD1, BRCA1, BRCA2, breast and ovarian cancer, BRIP1, carriership of a pathogenic familial variant, CDH1, CDKN2A, CHEK2, endometrial cancer, EPCAM, HBOC, Hereditary cancer, HNPCC, HOXB13, Lynch syndrome, MLH1, MSH2, MSH6, PALB2, pancreatic cancer, PMS2, prostate cancer, PTEN, RAD51C, RAD51D, STK11, TP53
| Material |
|
|
| Note |
Search for mutations or gene dosage changes known in the family, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53. | Preliminary findings of a known mutation or gene dosage change in the family are required for the analysis to be carried out. | Declaration of consent for genetic examination in accordance with GUMG required (see OF Human genetics or www.viollier.ch/en/SGMG_consent) | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. |
|
| Min. quantity | 4 mL | |
| Stability | 1 week / 2-8°C | |
| Duration | 3 weeks | |
| Frequency | 1 x per month | |
| Method | Next Generation Sequencing | |
| Price | CHF 338.40 | |
| Tariff | 338.40 TP |
Team of consultants
|
PhD
Christoph Noppen
FAMH Specialist in laboratory medicine, medical genetics
|
FAMH Specialist in laboratory medicine, medical genetics | T |
|
|
DSc
Henriette Kurth
FAMH Specialist in laboratory medicine, medical genetics
|
FAMH Specialist in laboratory medicine, medical genetics | T |
|
|
Dr. sc. nat.
Andrea Salzmann
Candidate FAMH Specialist in laboratory medicine, main field medical genetics
|
Candidate FAMH Specialist in laboratory medicine, main field medical genetics | T |
|